KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Acquisitions & Divestments: 2009-2024

Historic Change in Acquisitions & Divestments for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Dec 2024 value amounting to $39.7 million.

  • Rigel Pharmaceuticals' Change in Acquisitions & Divestments rose 245.50% to $20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.3 million, marking a year-over-year increase of 39.49%. This contributed to the annual value of $39.7 million for FY2024, which is 4.68% down from last year.
  • According to the latest figures from FY2024, Rigel Pharmaceuticals' Change in Acquisitions & Divestments is $39.7 million, which was down 4.68% from $41.6 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Change in Acquisitions & Divestments registered a high of $130.4 million during FY2020, and its lowest value of $39.7 million during FY2024.
  • Its 3-year average for Change in Acquisitions & Divestments is $60.9 million, with a median of $41.6 million in 2023.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first skyrocketed by 63.14% in 2022, then slumped by 58.86% in 2023.
  • Yearly analysis of 5 years shows Rigel Pharmaceuticals' Change in Acquisitions & Divestments stood at $130.4 million in 2020, then tumbled by 52.43% to $62.0 million in 2021, then soared by 63.14% to $101.2 million in 2022, then slumped by 58.86% to $41.6 million in 2023, then decreased by 4.68% to $39.7 million in 2024.